Unfortunately, Grail had bad news for investors in February when it released top-line results from the NHS and outlined that ...

HCA Healthcare to Offer GRAIL’s Galleri ® Multi-Cancer Early Detection (MCED) Test; HCA Healthcare’s Cancer Institute, Sarah Cannon, to Support Individuals Who Receive a Positive Signal NASHVILLE, ...

CANTON, Mass. & MENLO PARK, Calif.-- (BUSINESS WIRE)--Point32Health, the parent company of Harvard Pilgrim Health Care, and GRAIL, LLC, a health care company with a mission of detecting cancer early ...

Dec 17 (Reuters) - Gene sequencing company Illumina ILMN.O said on Sunday it will divest cancer diagnostic test maker Grail GRAL.O after the companies battled both U ...

GRAIL's Galleri Test Now Directly Available to Physicians in the U.S. Through Collaboration With Quest Diagnostics, Delivering a More Streamlined Provider and Patient Experience MENLO PARK, Calif. and ...

Add Yahoo as a preferred source to see more of our stories on Google. Multi-cancer blood tests are generally seen as the future of cancer detection. The promise is that with a few vials of blood, you ...

Collaboration With Epic Will Allow Clinicians to Seamlessly Order the Galleri Multi-Cancer Early Detection Test at the Point of Care MENLO PARK, Calif., April 7, 2026 /PRNewswire/ -- GRAIL, Inc.

Add Yahoo as a preferred source to see more of our stories on Google. Pancreatic cancer is the third leading cause of cancer-related deaths, trailing behind lung cancer and colorectal cancer, a trend ...

Gene sequencing company Illumina said on Sunday it will divest cancer diagnostic test maker Grail after the companies battled both U.S. and European antitrust enforcers for more than two years and ...

Grail said in a statement sent to Fierce Medtech that “the issue was in no way related to or caused by an incorrect Galleri laboratory test result.” Instead, per the company, its go-to telemedicine ...

CHICAGO (Reuters) - U.S. cancer diagnostic test maker Grail, which will list its shares on the Nasdaq on Tuesday after being spun out of Illumina, is betting that commercial partnerships with health ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...